RE: Investor communications - push for updates, offer insight, links and potentials plus your general vi23 Feb 2021 22:42
Also, we work with trade associations such as the PPMA, (https://www.ppma.co.uk/ppma.html) who can assist us, and any company as yourselves, to source machinery, staffing, routes to market, and offer general business advise.
May I suggest getting in touch with them to discuss your needs directly.
I am happy to directly put you in touch with contacts if required.
Additionally, I offer our services, with trained engineers, to inspect your machine and evaluate, if we can support you going forward, short and long term.
We can sign an NDA, and inspect the machine accordingly FOC, and offer our suggestions.
Also, as a company, we have vast experience and I am interested to evaluate your production needs in it’s entirety, as we can supply you with machinery from across our group.
Please see our website for our machinery range.
https://www.youtube.com/watch?v=VUnSwZ1UA78
https://www.hamer-fischbein.com/
https://www.duravant.com/our-brands.html
My contact details are listed below and as stated, I’d be happy to sign any NDA, to ensure sensitive information, is not released to market.
I would however, appreciate some communications to my concerns, and comments on the company’s strategy short and long term.
From Forbes yesterday but publish in HL sharecast:
Topline
Thousands of healthcare workers are refusing to take the Oxford-AstraZeneca vaccine over concerns about side effects and efficacy, with some arguing that they should be prioritized for the more effective doses from Pfizer and Moderna.
Key Facts
Multiple unions representing healthcare workers in Europe have said many of their members don’t want the vaccine developed by AstraZeneca PLC, which was found to be 62% effective at reducing symptomatic disease in its trials and 81% effective in later data when the two doses were spaced out longer (competitors showed 90% efficacy).
A group representing 3,000 doctors in Italy wrote a letter to the Italian government last week demanding that “private doctors and dentists be inoculated with mRNA vaccines” like those developed by Moderna and Pfizer and BioNTech, as opposed to AstraZeneca’s “since there is evidence they are more effective.”
Meanwhile, Germany and France have both reported that hundreds of thousands of AstraZeneca vials are sitting unused, as many skip vaccination appointments for AstraZeneca’s doses specifically.
“Medical staff need the most effective vaccine,” Jerome Marty, the president of a French doctor’s union told The Wall Street Journal in an interview earlier this week, adding: “We need to keep the AstraZeneca vaccine for healthy and young people.”
Sign In
Follow the stocks
